Dr. Vatsala Naageshwaran

Chief Executive Officer Franklin Biolabs, USA

Vatsala Naageshwaran has worked on numerous projects in support of NDA submissions that have received FDA and EMA approvals as well as with several leading generic companies to support successful ANDA submissions and market approvals of generic drugs since 2009 to date. She manages the ocular, medical device and PK services which are based in San Diego while continuing to support business development worldwide.

Prior to joining Absorption Systems, she has worked for several biotechnology / pharmaceutical companies as a research scientist with experience in drug discovery, assay validation, and product development. Her research has been featured at national conferences such as AAPS, SOT, AACR and EORTC and she has authored publications submitted to peer-reviewed journals. She has spoken at numerous forums and conducted workshops on clinically relevant drug transporters and non-clinical methods for establishing bioequivalence of oral and complex drug products. Vatsala has a Master’s degree in Biochemistry from Mt Holyoke College, MA and she is currently pursuing a Master’s degree in Pharmacometrics at the University of Maryland Baltimore and a PhD in Ocular Modelling at the University of Eastern Finland. Her research interests are in the areas of ophthalmology, pharmacokinetics and bioequivalence.

International Committee